How to Analyze Cell-Free DNA Sequencing Data from Cancer Patients to Identify Clinically Actionable Variants
In this webinar, whole exome sequencing data of tumor tissue and cell-free DNA derived from two cancer patients will be used to demonstrate how non-invasive liquid biopsies from the blood have the potential to aid in precision medicine. Using Partek® Flow® software, a powerful and easy-to-use bioinformatics tool, we will analyze raw sequence data from individuals with metastatic sarcoma and metastatic breast cancer to identify clinically actionable variants.
- Align and filter whole exome sequencing data
- Detect variants from tumor and cell-free DNA
- Perform annotation and filtering to prioritize variants